Immune globulin - Bio Products Laboratory

Drug Profile

Immune globulin - Bio Products Laboratory

Alternative Names: Gammaplex; Subgam; Subgam-VF

Latest Information Update: 16 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bio Products Laboratory
  • Class Immunoglobulins; Immunoproteins; Serum globulins
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Immunodeficiency disorders
  • Registered Immune thrombocytopenic purpura
  • Phase III Idiopathic thrombocytopenic purpura

Most Recent Events

  • 25 May 2017 Bio Products Laboratory completes a phase III trial in Immunodeficiency disorders (In children, In adolescents, In adults) in USA (SC) (NCT01884311)
  • 07 Feb 2017 Registered for Immune thrombocytopenic purpura (In adults) in USA (IV)
  • 07 Feb 2017 Registered for Immunodeficiency disorders (In adults) in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top